Dear Colleague,
What an exciting time to be in healthcare! As we think about increased acuity and the needs of patients, we can be comforted that the rapid advances in diagnostics, therapeutics, procedures, and care delivery models are reshaping how specialty care is delivered.
At the forefront of those advances is the integration of medical oncology, urology, and radiation oncology — with all three specialties increasingly sharing patient populations and clinical pathways, creating meaningful opportunities for deeper collaboration, and helping us strive to achieve our universal goals of better clinical outcomes, improved patient experience, lower total cost of care, and enhanced provider satisfaction.
Running a practice with one specialty is not an easy feat, let alone driving the integration across different specialties, as each has developed individual workflows, referral patterns, and priorities. However, it is very achievable and when done well, it can unlock significant organic growth through physician recruiting, launching and utilizing service lines and ancillary services, and managing expenses in a safe, fair, and efficient way including labor and real estate – two operational areas where practices can often benefit from additional insight and perspectives.
Another major area of focus that excites me is the clinical and business case for the expansion of service lines and ancillary services given the specialties’ complementary nature. Consistently, patient satisfaction scores can be linked to the availability of new therapies to meet patient needs. By taking a multidisciplinary approach, practices can justify the launch of these services with OneOncology’s support and proven track record of success with integrating these programs. For example, we’ve already seen how the clinical and business cases for PET/CT, pharmacy, Chronic Care Management, pathology, and IMRT were significantly enhanced by incorporating utilization of all three specialties. This, of course, does not preclude support of warranted projects that are specific to any one specialty — since our experience is evidence that although there is much that each specialty can share, often there are unique needs of each specialty’s patients that must be addressed.
It is an exciting time to be part of OneOncology. The company has continued to evolve to meet the needs of our practice partners and their patients. We are thrilled that our operations teams play a major role in driving our continued evolution.
Sincerely,
Ian Wong
Chief Operating Officer
OneOncology